Metronidazole



Combined with:

Yaz

Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 23.5%
Drug Use For Unknown Indication 14.4%
Urinary Tract Infection 6.5%
Infection 5.7%
Helicobacter Infection 4.3%
Tooth Infection 4.3%
Tooth Abscess 3.7%
Vaginitis Bacterial 3.7%
Pneumonia 3.5%
Rosacea 3.4%
Pain 3.4%
Clostridial Infection 3.1%
Diverticulitis 3.1%
Hypertension 3.1%
Brain Abscess 2.7%
Clostridium Difficile Colitis 2.6%
Liver Abscess 2.4%
Diarrhoea 2.2%
Vaginal Infection 2.2%
Crohn's Disease 2.2%
Vomiting 12.9%
Toxic Encephalopathy 10.7%
Encephalopathy 8.7%
Urticaria 7.5%
Paraesthesia 6.3%
Anaphylactic Reaction 4.6%
Drug Ineffective 4.6%
Neuropathy Peripheral 4.4%
Rash 4.4%
Neurotoxicity 4.0%
Psychotic Disorder 3.6%
Vertigo 3.6%
Stevens-johnson Syndrome 3.4%
White Blood Cell Count Increased 3.4%
Somnolence 3.2%
Dysarthria 3.0%
Clostridium Difficile Colitis 2.8%
Drug Interaction 2.8%
Nausea 2.8%
Toxicity To Various Agents 2.8%
Secondary
Product Used For Unknown Indication 31.6%
Drug Use For Unknown Indication 17.3%
Helicobacter Infection 5.3%
Drug Abuse 5.3%
Pneumonia 4.6%
Abdominal Infection 3.4%
Hypertension 3.2%
Pain 3.0%
Sepsis 2.8%
Prophylaxis 2.8%
Urinary Tract Infection 2.7%
Neoplasm 2.5%
Infection 2.4%
Antibiotic Prophylaxis 2.1%
Cellulitis 2.1%
Diverticulitis 1.9%
Oedema 1.8%
Acute Myeloid Leukaemia 1.8%
Pyrexia 1.8%
Abscess 1.6%
Vomiting 15.9%
Death 7.4%
Swollen Tongue 6.0%
White Blood Cell Count Increased 5.1%
Clostridium Difficile Colitis 4.9%
Thrombocytopenia 4.9%
International Normalised Ratio Increased 4.7%
Renal Failure Chronic 4.7%
Toxic Epidermal Necrolysis 4.7%
Pyrexia 4.5%
Weight Decreased 4.5%
Toxic Encephalopathy 4.3%
Metabolic Acidosis 4.0%
Encephalopathy 3.8%
Myocardial Infarction 3.8%
Stevens-johnson Syndrome 3.6%
Drug Ineffective 3.4%
Neutropenic Sepsis 3.4%
Urticaria 3.4%
Delirium 3.1%
Concomitant
Product Used For Unknown Indication 34.2%
Drug Use For Unknown Indication 18.5%
Crohn's Disease 7.3%
Pain 5.7%
Hypertension 4.4%
Prophylaxis 4.2%
Infection 3.2%
Diffuse Large B-cell Lymphoma 2.4%
Depression 2.4%
Nausea 2.2%
Contraception 2.0%
Constipation 1.7%
Hiv Infection 1.6%
Acute Myeloid Leukaemia 1.6%
Multiple Myeloma 1.6%
Gastrooesophageal Reflux Disease 1.5%
Pneumonia 1.4%
Sepsis 1.4%
Breast Cancer 1.4%
Diarrhoea 1.3%
Vomiting 14.3%
Weight Decreased 10.8%
Sepsis 8.4%
Pulmonary Embolism 7.9%
Crohn's Disease 5.8%
Pain 5.1%
Thrombocytopenia 4.8%
Septic Shock 4.2%
Pyrexia 4.0%
Renal Failure Acute 3.9%
Renal Failure 3.6%
Weight Increased 3.6%
Death 3.3%
Urinary Tract Infection 3.1%
Nausea 3.0%
Respiratory Failure 3.0%
White Blood Cell Count Increased 2.9%
Deep Vein Thrombosis 2.8%
Tremor 2.7%
Abdominal Pain 2.6%
Interacting
Product Used For Unknown Indication 24.8%
Hypertension 11.7%
Periorbital Cellulitis 9.2%
Drug Use For Unknown Indication 7.8%
Chest Pain 4.6%
Pulmonary Embolism 4.1%
Urinary Tract Infection 4.1%
Depression 3.9%
Diverticulitis 3.4%
Psoriasis 3.4%
Tooth Disorder 3.0%
Torsade De Pointes 3.0%
Type 2 Diabetes Mellitus 3.0%
Haematoma Infection 2.5%
Cellulitis 2.1%
Chalazion 2.1%
Lung Disorder 1.8%
Pneumonia 1.8%
Urosepsis 1.8%
Prophylaxis 1.6%
Drug Interaction 15.3%
Pyrexia 12.5%
Clostridium Difficile Colitis 8.3%
Vomiting 8.3%
International Normalised Ratio Increased 6.9%
Intraocular Pressure Increased 6.9%
Toxicity To Various Agents 5.6%
Hypotension 4.2%
Malaise 4.2%
Overdose 4.2%
Convulsion 2.8%
Drug Toxicity 2.8%
Dysgeusia 2.8%
Hypoglycaemia 2.8%
Memory Impairment 2.8%
Osmotic Demyelination Syndrome 2.8%
Torsade De Pointes 2.8%
Cholestasis 1.4%
Electrocardiogram Qt Prolonged 1.4%
Feeling Hot 1.4%